SCHEMBL23913450

SCHEMBL23913450

c1ccc(-c2ccc3c(c2)oc2cc(-c4nc(-c5ccc(-c6cccc7sc8ccccc8c67)cc5)nc(-c5ccc6c(c5)oc5ccccc56)n4)ccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.37
MMP12 P39900 1/20 0.36
MMP13 P45452 1/20 0.36
F9 P00740 1/20 0.35
SLC9A1 P19634 1/20 0.34
BRDT Q58F21 1/20 0.34
PRKDC P78527 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
AHR P35869 1/20 0.33
LIMK1 P53667 1/20 0.33
MAPT P10636 3/20 0.33
ALOX5 P09917 1/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 2/20 0.33
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25645660 0.99 HCRTR1 (0.36) HCRTR1MMP12MMP13F9SLC9A1
SCHEMBL25645656 0.99 F9 (0.36) HCRTR1MMP12MMP13F9SLC9A1
SCHEMBL25645611 0.99 F9 (0.36) HCRTR1MMP12MMP13F9SLC9A1
SCHEMBL25646009 0.98 F9 (0.36) HCRTR1MMP12MMP13F9SLC9A1
SCHEMBL23913427 0.97 PLA2G2A (0.36) HCRTR1MMP12MMP13F9SLC9A1
SCHEMBL25645671 0.97 HCRTR1 (0.36) HCRTR1MMP12MMP13F9BRDT
SCHEMBL25851955 0.97 HCRTR1 (0.36) HCRTR1MMP12MMP13F9SLC9A1
SCHEMBL25851956 0.96 HCRTR1 (0.35) HCRTR1MMP12MMP13F9SLC9A1
SCHEMBL23913442 0.96 F9 (0.35) HCRTR1MMP12MMP13F9SLC9A1
SCHEMBL25645666 0.96 HCRTR1 (0.37) HCRTR1MMP12MMP13F9SLC9A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 HCRTR1 476/4885MMP12 4705/4885MMP13 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.